FDA Issues Alert to Clinical Laboratories About the Effects of New SARS-CoV-2 Variant on Testing
A new SARS-CoV-2 variant, B.1.1.7, was identified late last year in the UK, prompting the FDA to monitor existing tests, such as TaqPath, Linea, and Accula.
HHS Announces $22 Billion for COVID-19 Testing and Monitoring
HHS details state-level support for COVID-19 testing and monitoring, with the more than $19 billion to be allocated through the existing CDC ELC cooperative agreement.
One Clinical Laboratory Now Offering Its COVID-19 Diagnostic Test On Amazon
While diagnostic testing for COVID-19 slowly shifts away from clinical laboratories, these changes can be beneficial.